Asthma, asthma medication and autonomic nervous system dysfunction

Clinical Physiology

Volumn 21, Issue 2, 2001, Pages 260-269

  Jartti, Tuomas ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

2 adrenergic agonist; Anticholinergic; Asthma; Autonomic nervous system; Glucocorticoid

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; CATECHOLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FORMOTEROL; GLUCOCORTICOID; HORMONE RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; SALBUTAMOL; SALMETEROL; TERBUTALINE; TIOTROPIUM BROMIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

AIRWAY CONDUCTANCE; ARTICLE; ASTHMA; AUTONOMIC NEUROPATHY; BETA ADRENERGIC STIMULATION; BRONCHUS; BRONCHUS SECRETION; CHOLINERGIC STIMULATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SYNTHESIS; HEART PALPITATION; HUMAN; LONG TERM CARE; LUNG BLOOD FLOW; LUNG ENDOTHELIUM; PATHOGENESIS; PERMEABILITY; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; SMOOTH MUSCLE TONE;

ADRENERGIC BETA-AGONISTS; ASTHMA; AUTONOMIC NERVOUS SYSTEM DISEASES; CATECHOLAMINES; CHILD; CHOLINERGIC ANTAGONISTS; CIRCADIAN RHYTHM; GLUCOCORTICOIDS; HUMANS; INFLAMMATION;

EID: 0035051807     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.2001.00323.x     Document Type: Article

References (90)

1. Nocturnal airflow obstruction, histamine, and the autonomic central nervous system in children with allergic asthma
2. Adrenergic response in children with asthma on exogenous stimuli
3. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m (2) muscarinic receptor dysfunction, and antiviral effects
4. Pulmonary function and acid application in the oesophagus
5. Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma
6. Neural control of human airways in health and disease
7. Neural mechanisms in asthma
8. Beta-adrenergic receptors and their regulation
9. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease
10. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma
11. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin
12. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways
13. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a) symptomatic gastro-oesophageal reflux
14. Salmeterol tachyphylaxis in steroid treated asthmatic subjects
15. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol
16. Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen
17. Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease
18. Bronchoconstricor action of neuropeptide Y (NPY) in isolated guinea pig airways
19. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma
20. Autoradiographic visualization of beta-adrenoceptors in asthmatic lung
21. Serevent nationwide surveillance study: Comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment
22. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma
23. Prescribed Fenoterol and death from asthma in New Zealand
24. Randomized controlled trial of ipratripium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma
25. Is the association between inhaled beta-agonist use and life-threathing asthma because of confounding severity?
26. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs
27. 2 muscarinic receptor function in guinea-pig lungs is inhibited by indomethacin
28. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge
29. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
30. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients
31. In vivo demonstration of α-2-adrenoceptor-mediated inhibition of the excitatory non-cholinergic neurotransmission in guinea pig airways
32. The superiority of combination beclomethasone and salbutamol over standard dosing of salbutamol in the treatment of chronic asthma
33. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
34. Autonomic responses of asthmatic children
35. Psychophysiological reactivity of asthmatic children
36. Induction of nitric oxide synthase in asthma
37. -interferon-induced nitric oxide-mediated inhibition of vaccina virus replication
38. Muscarinic and beta-adrenergic receptor expression in peripheral lung from normal and asthmatic patients
39. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects
40. Inhalation of nitric oxide modulates adult human bronchial tone
41. Cardiovascular autonomic regulation in asthmatic children evidenced by spectral analysis of heart rate and blood pressure variability
42. The acute effects of inhaled salbutamol on the variability of R-R interval and systolic blood pressure assessed by spectral analysis
43. The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure
44. Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children
45. Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children
46. Rebound airway obstruction and responsiveness after cessation of terbutaline: Effects of budesonide
47. The cholinergic nervous system and immediate hypersensitivity. 1. Eccrine sweat gland responses in allergic patients
48. Autonomic nervous system abnormalities and allergy
49. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea-pigs
50. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma
51. Inhibition of viral replication by interferon - Induced nitric oxide synthase
52. Increased nitric oxide in exhaled air of asthmatics patients
53. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
54. Sympathoadrenal responses to bronchoconstriction in asthma: An invasive and kinetic study of plasma catecholamines
55. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: A randomized clinical trial
56. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics
57. Non-adrenergic, non-cholinergic nervous system and overnight airway calibre in asthmatic and normal subjects
58. Non-adrenergic, non-cholinergic function in the human airway
59. Salmeterol: A study by prescription-event monitoring in a UK cohort of 15,407 patients
60. Characteristics and mechanisms of nocturnal asthma
61. Histamine-induced end-tidal inspiratory activity and lung receptors in cats
62. Detection and treatment of early asthma
63. The parasympathetic nervous system and the diurnal variation of lung mechanics in asthma
64. The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies
65. Inhibition by sr 59119a of isoprenaline-, forskolin- and vip-induced relaxation of human isolated bronchi
66. 2-agonists in asthma
67. Substance P immunoreactive nerve fibers in airways from asthmatics and non-asthmatics
68. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
69. Hyperresponsiveness to non-adrenergic, non-cholinergic vagal stimulation following multiple antigen challenge in guinea-pigs
70. Salbutamol in the 1980s. A reappraisal of its clinical efficacy
71. Effect of nebulized ipratropium bromide on the hospitalization rates of children with asthma
72. Bronchoconstriction induced by citric acid inhalation in guinea pigs: Role of tachykinins, bradykinin, and nitric oxide
73. Salmeterol xinafoate in children on high dose inhaled steroids
74. Glucocorticoid inhibition of cytokine production: Relevance to antiallergenic actions
75. Role of substance P in cough
76. Clinical dysautonomia in patients with bronchial asthma. Study with seven autonomic Function tests
77. Cholinergic nervous system and immediate hypersensitivity: II an analysis of pulillary responses
78. Allergen challenge of passively sensitized human bronchi alters M2 and beta2 receptor function
79. Autoradiographic localization of beta-adrenoceptors in asthmatic human lung
80. 2-agonists and the risk of death and near death from asthma
81. Parasympathetic activity assessed by diving reflex and by airway response to methacholine in bronchial asthma
82. Regulation of immune response by nitric oxide differentially produced by T-helper type 1 and T-helper type 2 cells
83. Neurophysiology of mast cell-nerve interactions in the airways
84. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline
85. Autonomic innervation of human airways: Structure, function and patophysiology in asthma
86. Budesonide and terbutaline or terbutaline alone in children with mild asthma: Effects on bronchial hyperresponsiveness and diurnal variation in peak flow
87. Beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma
88. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge
89. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
90. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: A case-control study